Labor/Employment
Dec. 2, 2022
Robins Geller seeks OK of $141M settlement for pension fund
A complaint filed four years ago alleged that McKesson executives participated in an unlawful price-fixing scheme with manufacturers and wholesalers in the sale of generic pharmaceutical drugs.
Attorneys for a pension fund, the lead plaintiff in a securities fraud class action against McKesson, are asking a San Francisco federal judge to approve a $141 million settlement with the pharmaceutical company.
"This was a hard-fought case, from beginning to end, and it's a strong result for the class and reflects a lot of determination on the part of our client to get the best result for investors," said the lead plaintiffs' counsel, Ro...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In